Enhance your practice with CME and tools that focus on the management of neurological conditions.
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
Outcome Measures Capture Progression in Late-Onset TK2d
More Than a Myopathy: The Lived Experience of TK2d
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Recurrence as the Rule: BD Symptoms Persist and Cycle
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
ADHD Is Linked to a Broad Burden of GI Symptoms
What’s Still Missing in ADHD Care?
Diagnosing Adult ADHD in the Social Media Era
Stroke-Like Symptoms During Treatment: Safety First
Dani Cabral, MD
David Weisman, MD
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
Talking Through Benefits, Risks, and Patient Priorities
Who Is Ready for Amyloid-Targeting Therapy?
Antithrombotics and Amyloid Therapy: Balancing Risk
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.